NASDAQ:ZURA
Zura Bio Ltd
Zura Bio Ltd reported net income of −$68.7M in fiscal 2025. Free cash flow was −$64.9M, and the diluted share count rose 25.4%.Summary generated from Zura Bio Ltd's SEC filings. Latest annual report filed Mar 19, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−55.3%
Debt / equityn/a
Free cash flow−$64.9M
FCF marginn/a
Share count change+25.4%
Financials
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | n/a |
| Operating income | −3 | −63 | −55 | −75 |
| Net income | −26 | −60 | −52 | −69 |
| Free cash flow | n/a | n/a | −28 | −65 |
Recent filings
- 8-KRegulation FD disclosure
Aug 17, 2026 - 8-KResults of operations and financial condition
Aug 11, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 11, 2026 - 8-KRegulation FD disclosure
Jul 1, 2026 - 4Insider transaction report
Jun 22, 2026 - 4Insider transaction report
Jun 22, 2026 - 8-KDirector or officer change
Jun 18, 2026 - 8-KDirector or officer change
May 22, 2026